Annual FCF
-$33.62 M
-$5.95 M-21.52%
December 31, 2023
Summary
- As of February 6, 2025, LRMR annual free cash flow is -$33.62 million, with the most recent change of -$5.95 million (-21.52%) on December 31, 2023.
- During the last 3 years, LRMR annual FCF has risen by +$8.64 million (+20.44%).
- LRMR annual FCF is now -47.59% below its all-time high of -$22.78 million, reached on December 31, 2019.
Performance
LRMR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$24.61 M
-$10.35 M-72.54%
September 30, 2024
Summary
- As of February 6, 2025, LRMR quarterly free cash flow is -$24.61 million, with the most recent change of -$10.35 million (-72.54%) on September 30, 2024.
- Over the past year, LRMR quarterly FCF has dropped by -$10.35 million (-72.54%).
- LRMR quarterly FCF is now -318.65% below its all-time high of -$5.88 million, reached on September 30, 2022.
Performance
LRMR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$58.62 M
-$15.41 M-35.65%
September 30, 2024
Summary
- As of February 6, 2025, LRMR TTM free cash flow is -$58.62 million, with the most recent change of -$15.41 million (-35.65%) on September 30, 2024.
- Over the past year, LRMR TTM FCF has dropped by -$15.41 million (-35.65%).
- LRMR TTM FCF is now -552.90% below its all-time high of -$8.98 million, reached on March 31, 2020.
Performance
LRMR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
LRMR Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -21.5% | -72.5% | -35.6% |
| 3 y3 years | +20.4% | -72.5% | -35.6% |
| 5 y5 years | -47.6% | -72.5% | -35.6% |
LRMR Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -21.5% | +20.8% | -318.6% | at low | -113.4% | at low |
| 5 y | 5-year | -47.6% | +20.8% | -318.6% | at low | -552.9% | at low |
| alltime | all time | -47.6% | +20.8% | -318.6% | at low | -552.9% | at low |
Larimar Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$24.61 M(+72.5%) | -$58.62 M(+35.7%) |
| Jun 2024 | - | -$14.26 M(+37.0%) | -$43.22 M(+19.0%) |
| Mar 2024 | - | -$10.41 M(+11.4%) | -$36.32 M(+8.5%) |
| Dec 2023 | -$33.62 M(+21.5%) | -$9.34 M(+1.6%) | -$33.46 M(+8.7%) |
| Sep 2023 | - | -$9.20 M(+24.9%) | -$30.79 M(+12.1%) |
| Jun 2023 | - | -$7.37 M(-2.5%) | -$27.47 M(-0.8%) |
| Mar 2023 | - | -$7.55 M(+13.2%) | -$27.69 M(+0.1%) |
| Dec 2022 | -$27.67 M | -$6.67 M(+13.5%) | -$27.67 M(-4.3%) |
| Sep 2022 | - | -$5.88 M(-22.5%) | -$28.92 M(-18.6%) |
| Jun 2022 | - | -$7.59 M(+0.7%) | -$35.54 M(-8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$7.53 M(-5.0%) | -$38.77 M(-8.7%) |
| Dec 2021 | -$42.44 M(+0.4%) | -$7.93 M(-36.5%) | -$42.44 M(-4.3%) |
| Sep 2021 | - | -$12.49 M(+15.5%) | -$44.37 M(+2.9%) |
| Jun 2021 | - | -$10.81 M(-3.5%) | -$43.10 M(-3.1%) |
| Mar 2021 | - | -$11.21 M(+13.7%) | -$44.49 M(+5.3%) |
| Dec 2020 | -$42.26 M(+85.5%) | -$9.86 M(-12.2%) | -$42.26 M(+30.4%) |
| Sep 2020 | - | -$11.23 M(-8.0%) | -$32.41 M(+53.0%) |
| Jun 2020 | - | -$12.20 M(+35.9%) | -$21.18 M(+135.9%) |
| Mar 2020 | - | -$8.98 M | -$8.98 M |
| Dec 2019 | -$22.78 M | - | - |
FAQ
- What is Larimar Therapeutics annual free cash flow?
- What is the all time high annual FCF for Larimar Therapeutics?
- What is Larimar Therapeutics annual FCF year-on-year change?
- What is Larimar Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly FCF year-on-year change?
- What is Larimar Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Larimar Therapeutics?
- What is Larimar Therapeutics TTM FCF year-on-year change?
What is Larimar Therapeutics annual free cash flow?
The current annual FCF of LRMR is -$33.62 M
What is the all time high annual FCF for Larimar Therapeutics?
Larimar Therapeutics all-time high annual free cash flow is -$22.78 M
What is Larimar Therapeutics annual FCF year-on-year change?
Over the past year, LRMR annual free cash flow has changed by -$5.95 M (-21.52%)
What is Larimar Therapeutics quarterly free cash flow?
The current quarterly FCF of LRMR is -$24.61 M
What is the all time high quarterly FCF for Larimar Therapeutics?
Larimar Therapeutics all-time high quarterly free cash flow is -$5.88 M
What is Larimar Therapeutics quarterly FCF year-on-year change?
Over the past year, LRMR quarterly free cash flow has changed by -$10.35 M (-72.54%)
What is Larimar Therapeutics TTM free cash flow?
The current TTM FCF of LRMR is -$58.62 M
What is the all time high TTM FCF for Larimar Therapeutics?
Larimar Therapeutics all-time high TTM free cash flow is -$8.98 M
What is Larimar Therapeutics TTM FCF year-on-year change?
Over the past year, LRMR TTM free cash flow has changed by -$15.41 M (-35.65%)